WVU gets FDA approval for clinical trial of drug to treat eye cancer ‘from the inside out’
Uveal melanoma may be a rare form of cancer, but it’s almost always fatal. No treatments currently available for it can significantly lengthen someone’s life. WVU School of Pharmacy researcher Mark McLaughlin and his colleagues are working to change that. The Food and Drug Administration recently approved a clinical trial of their new drug that precisely targets uveal melanoma, even after the cancer has spread to other parts of the body.